Share on PinterestWomen with diabetes may get the strongest cardiovascular protection from GLP-1 agonists. Image credit: Kathryn Gamble for The Washington Post via Getty Images. Diabetes, a condition where blood glucose levels cannot be controlled, affects more than 10% of the adult population worldwide, and more than 90% of those have type 2 diabetes. Although … Read more
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson’s, finds a new study led by UCL researchers. The world’s largest and longest trial of exenatide in people with Parkinson’s disease was funded by the National Institute for Health & Care Research (NIHR) with support for … Read more
Over the last 20 years, metabolic dysfunction–associated steatohepatitis (MASH) has been a partial driver of primary liver cancer (PLC), according to a review published in Clinical Gastroenterology and Hepatology.1 The investigators believe their decades-spanning analysis underscores the need to address access barriers to anti-obesity therapeutics | image credit: BillionsPhotos.com – stock.adobe.com Although MASH remains one … Read more
Found, a telehealth startup that treats obesity with medication and lifestyle coaching, unveiled new research showing tens of thousands of its patients lost significant amounts … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. Source link
Digbi Health Takes Precision Approach to Obesity Treatment with Cutting-Edge GLP-1 Companion Program Palo Alto, California – Digbi Health, a pioneer in the field of Precision Biology, has announced significant updates to its GLP-Compass program, poised to revolutionize obesity treatment with a hyper-personalized approach. Digbi Health’s GLP-Compass, already recognized as the industry leader in Precision … Read more
PALO ALTO, Calif., Jan. 17, 2025 (GLOBE NEWSWIRE) — Digbi Health, a pioneer in Precision Biology, is advancing obesity management with groundbreaking enhancements to GLP-Compass (™), its industry-leading obesity test. Digbi Health is introducing innovative components to personalize nutritional and pharmacotherapy support to ensure everyone receives the right care based on their biology and lifestyle. … Read more
Welcoming a newborn is something many couples dream of doing, but it can get complicated when conceiving becomes a roadblock. Infertility affects one in six people, but obesity can also be a problem. When diet and exercise aren’t enough to lose weight, bariatric surgery can become an option. Yet a new national survey by Orlando … Read more
Researchers discover a gut-microbe-driven pathway involving pantothenate and GLP-1 that could revolutionize sugar consumption management and metabolic health strategies. Study: Free fatty acid receptor 4 modulates dietary sugar preference via the gut microbiota. Image Credit: ya_create / Shutterstock In a recent study published in the journal Nature Microbiology, researchers in China investigated the role of the free … Read more